# Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty

> **NCT05449327** · NA · COMPLETED · sponsor: **Chiayi Christian Hospital** · enrollment: 150 (actual)

## Conditions studied

- Venous Thromboembolism
- Arthroplasty

## Interventions

- **DRUG:** Rivaroxaban 10 MG

## Key facts

- **NCT ID:** NCT05449327
- **Lead sponsor:** Chiayi Christian Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-01
- **Primary completion:** 2025-09-21
- **Final completion:** 2025-09-21
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05449327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05449327, "Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05449327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*